Wednesday, October 5, 2022 Advancing Alzheimer’s research
Here are some of the innovative ways that Sunnybrook clinicians and researchers are on the leading edge of research in the detection, prevention, and treatment of Alzheimer’s and dementia.
Tuesday, October 4, 2022 New research will help personalize cardiac prevention therapies in the future
New recently published findings in the Journal of the American College of Cardiology show that recalibration of existing risk scores using contemporary population-level data can improve risk estimates, more precisely determining whether a patient should be prescribed cholesterol-lowering statins.
Tuesday, September 20, 2022 New name for our Education Research Unit
As of today, Sunnybrook’s Education Research Unit (ERU) will be known as the: Sunnybrook Hub for Applied Research in Education (SHARE).
Thursday, September 15, 2022 Sunnybrook-led trial aims to treat prostate cancer with improved precision
A new Canadian trial designed and led by Sunnybrook Health Sciences Centre will determine whether Stereotactic Ablative Body Radiotherapy (SABR) can replace the standard brachytherapy boost for men with unfavourable risk prostate cancer.
Monday, September 12, 2022 First in the world: Direct-to-brain delivery of therapeutic in Parkinson’s disease using focused ultrasound is safe
A team of researchers from Sunnybrook Health Sciences Centre and University Health Network (UHN) are the first in the world to demonstrate that focused ultrasound technology can safely be used to deliver a therapeutic to targeted brain regions in patients with Parkinson’s disease (PD).
